Steven Prelack's Net Worth
$334 Thousand
Who is Steven Prelack?
Steven Prelack does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PIERIS PHARMACEUTICALS, INC., Aerpio Pharmaceuticals, Inc., and PRO PHARMACEUTICALS INC.
SEC CIK
Steven Prelack's CIK is 0001302315
Past Insider Trading and Trends
2014 was Steven Prelack's most active year for acquiring shares with 7 total transactions. Steven Prelack's most active month to acquire stocks was the month of December. 2014 was Steven Prelack's most active year for disposing of shares, totalling 8 transactions. Steven Prelack's most active month to dispose stocks was the month of December. 2014 saw Steven Prelack paying a total of $242,994.55 for 120,442 shares, this is the most they've acquired in one year. In 2014 Steven Prelack cashed out on 216,010 shares for a total of $314,008.62, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PIERIS PHARMACEUTICALS, INC. (PIRS) Snapshot price: $15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aerpio Pharmaceuticals, Inc. (AADI) Snapshot price: $1.82
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +101.51% | 12.33K |
$1.52 | $18,747.68 | 24.48K |
Jun 30
| |||
Form 4
|
∞
| 12.15K |
$1.54 | $18,748.99 | 12.15K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GALECTIN THERAPEUTICS INC (GALT) Snapshot price: $2.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
| +3,550.85% | 104.25K |
—
|
—
| 107.19K |
Mar 12 - Apr 8
| |||
Form 4
| -96.63% | -84.28K |
—
|
—
| 2.94K |
Nov 18
| |||
Form 4
| -6.44% | -6.00K |
$11.84 | -$71,040.00 | 87.22K |
Apr 11
| |||
Form 4
| +3,075.03% | 90.28K |
$7.98 | $25.93 | 93.22K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 28
| |||
Form 4
| +22.33% | 536 |
$3.25 | -$2.06 | 2.94K |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
No matching records found |